Monoamine Oxidase Inhibitors
"Monoamine Oxidase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
| Descriptor ID |
D008996
|
| MeSH Number(s) |
D27.505.519.389.616
|
| Concept/Terms |
Monoamine Oxidase Inhibitors- Monoamine Oxidase Inhibitors
- Inhibitors, Monoamine Oxidase
- Monoamine Oxidase Inhibitor
- Inhibitor, Monoamine Oxidase
- MAO Inhibitors
- Inhibitors, MAO
|
Below are MeSH descriptors whose meaning is more general than "Monoamine Oxidase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Monoamine Oxidase Inhibitors".
This graph shows the total number of publications written about "Monoamine Oxidase Inhibitors" by people in this website by year, and whether "Monoamine Oxidase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monoamine Oxidase Inhibitors" by people in Profiles.
-
Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. Nicotine Tob Res. 2015 Sep; 17(9):1126-33.
-
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy. Addiction. 2010 Sep; 105(9):1660-8.